- Relling MVet al (1999) Mercaptopurine ther-
apy intolerance and heterozygosity at the
thiopurine S-methyltransferase gene locus. J
Natl Cancer Inst 91(23):2001–2008 - Relling MV, Evans WE (2015) Pharmacoge-
nomics in the clinic. Nature 526(7573):343 - Schena M et al (1995) Quantitative monitor-
ing of gene expression patterns with a com-
plementary DNA microarray. Science 270
(5235):467 - McCarroll SA et al (2008) Integrated detec-
tion and population-genetic analysis of SNPs
and copy number variation. Nat Genet 40
(10):1166–1174 - Davies JJ, Wilson IM, Lam WL (2005) Array
CGH technologies and their applications to
cancer genomes. Chromosom Res 13
(3):237–248 - Southern E, Mir K, Shchepinov M (1999)
Molecular interactions on microarrays. Nat
Genet 21:5–9 - Zhang L, Miles MF, Aldape KD (2003) A
model of molecular interactions on short oli-
gonucleotide microarrays. Nat Biotechnol 21
(7):818–821 - Schena M (1999) DNA microarrays: a practi-
cal approach. Oxford University Press,
New York, NY - Quackenbush J (2002) Microarray data nor-
malization and transformation. Nat Genet
32:496–501 - Johnson JM et al (2003) Genome-wide sur-
vey of human alternative pre-mRNA splicing
with exon junction microarrays. Science 302
(5653):2141–2144 - Matsuzaki H et al (2004) Genotyping over
100,000 SNPs on a pair of oligonucleotide
arrays. Nat Methods 1(2):109–111 - Mullighan CG, Downing JR (2009)
Genome-wide profiling of genetic alterations
in acute lymphoblastic leukemia: recent
insights and future directions. Leukemia 23
(7):1209–1218 - Yang YH et al (2002) Normalization for
cDNA microarray data: a robust composite
method addressing single and multiple slide
systematic variation. Nucleic Acids Res 30(4):
e15–e15 - Irving JA et al (2005) Loss of heterozygosity
in childhood acute lymphoblastic leukemia
detected by genome-wide microarray single
nucleotide polymorphism analysis. Cancer
Res 65(8):3053–3058 - Huyghe JR et al (2013) Exome array analysis
identifies new loci and low-frequency variants
influencing insulin processing and secretion.
Nat Genet 45(2):197–201
48. Bertone P et al (2004) Global identification of
human transcribed sequences with genome
tiling arrays. Science 306(5705):2242–2246
49. Rhodes DR, Chinnaiyan AM (2005) Integra-
tive analysis of the cancer transcriptome. Nat
Genet 37:S31–S37
50. Bullinger L et al (2004) Use of gene-
expression profiling to identify prognostic
subclasses in adult acute myeloid leukemia.
N Engl J Med 350(16):1605–1616
51. Metzeler KH et al (2011) TET2 mutations
improve the new European LeukemiaNet
risk classification of acute myeloid leukemia:
a Cancer and Leukemia Group B study. J Clin
Oncol 29(10):1373–1381
52. Yang JJ et al (2009) Genome-wide interroga-
tion of germline genetic variation associated
with treatment response in childhood acute
lymphoblastic leukemia. JAMA 301
(4):393–403
53. Bassan R, Hoelzer D (2011) Modern therapy
of acute lymphoblastic leukemia. J Clin Oncol
29(5):532–543
54. Pui C-H et al (2004) Improved outcome for
children with acute lymphoblastic leukemia:
results of total therapy study XIIIB at St
Jude Children’s Research Hospital. Blood
104(9):2690–2696
55. Simon RM (2003) Design and analysis of
DNA microarray investigations. Springer Sci-
ence & Business Media, New York, NY
56. Rabbee N, Speed TP (2006) A genotype call-
ing algorithm for affymetrix SNP arrays. Bio-
informatics 22(1):7–12
57. Korn JM et al (2008) Integrated genotype
calling and association analysis of SNPs, com-
mon copy number polymorphisms and rare
CNVs. Nat Genet 40(10):1253–1260
58. Hubbell E, Liu W-M, Mei R (2002) Robust
estimators for expression analysis. Bioinfor-
matics 18(12):1585–1592
59. Xu H et al (2013) Novel susceptibility variants
at 10p12.31-12.2 for childhood acute lym-
phoblastic leukemia in ethnically diverse
populations. J Natl Cancer Inst 105
(10):733–742
60. Neale BM et al (2010) Meta-analysis of
genome-wide association studies of
attention-deficit/hyperactivity disorder. J
Am Acad Child Adolesc Psychiatry 49
(9):884–897
61. Mullighan CG et al (2007) Genome-wide
analysis of genetic alterations in acute lym-
phoblastic leukaemia. Nature 446
(7137):758–764
62. Mullighan CG et al (2008) BCR–ABL1 lym-
phoblastic leukaemia is characterized by the
408 Heng Xu and Yang Shu